Drug Shortage Report for TEVA-ECTOSONE
Report ID | 179180 |
Drug Identification Number | 00535435 |
Brand name | TEVA-ECTOSONE |
Common or Proper name | TEVA-ECTOSONE 0.1% REGULAR CREAM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BETAMETHASONE |
Strength(s) | 0.1% |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 450g |
ATC code | D07AC |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-21 |
Estimated end date | 2023-12-20 |
Actual end date | 2023-12-13 |
Shortage status | Resolved |
Updated date | 2023-12-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-02-09 | French | Compare |
v3 | 2023-02-09 | English | Compare |
v2 | 2022-12-22 | French | Compare |
v1 | 2022-12-22 | English | Compare |